Sign in

CIK 0001875558

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nuvectis Pharma, Inc.

Sign in to watch
Ticker
NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
862405608
Phone
+1 360-837-7232
Business address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
  1. 4 Grant or award Director acquired 30,000 shares (grant or award)
  2. 4 Grant or award Director acquired 30,000 shares (grant or award)
  3. 4 Open-market buy 10% owner bought 21,167 shares at $8.11 ($171,664)
  4. 4/A Open-market buy 10% owner bought 27,662 shares at an average $8.94 ($247,263)
  5. 4 Open-market buy 10% owner bought 27,411 shares at an average $8.60 ($235,647)
  6. 4 Open-market buy 10% owner bought 240,000 shares at $5.00 ($1,200,000)
  7. 4 Grant or award Chief Dev. & Ops. Officer acquired 150,000 shares (grant or award)
  8. 4 Grant or award Chief Science & Business Off acquired 150,000 shares (grant or award)
  9. 4 Grant or award Vice President, Finance acquired 51,000 shares (grant or award)
  10. 4 Grant or award Chairman & CEO acquired 250,000 shares (grant or award)
  11. 4 Open-market buy Chairman & CEO bought 4,500 shares at $4.65 ($20,925)
  12. 4/A Open-market buy 10% owner bought 49,121 shares at an average $4.66 ($228,941)
  13. 4 Open-market buy 10% owner bought 17,000 shares at $4.70 ($79,900)
  14. 4 Open-market buy Chief Science & Business Off bought 2,000 shares at $4.99 ($9,980)
  15. 4 Open-market buy Chairman & CEO bought 20,000 shares at $4.92 ($98,400)
  16. 4 Open-market sale Vice President, Finance sold 2,755 shares at $8.16 ($22,478)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 30,000 shares (grant or award)
  20. 4 Open-market buy Chairman & CEO bought 1,940 shares at $6.74 ($13,076)

Page 2 of 7 · 139 filings